第一作者机构:[1]Yunnan Kungang Hosp, Dept Surg, Anning, Peoples R China
推荐引用方式(GB/T 7714):
Wang K.,Zhang H.,Wang X.,et al.Clinical relevance of immune factors beyond CD8+T cells and mutation status of EGFR and ALK in patients with non-small cell lung cancer[J].ANNALS OF ONCOLOGY.2020,31:S809-S809.doi:10.1016/j.annonc.2020.08.126.
APA:
Wang, K.,Zhang, H.,Wang, X.,Liu, Y.,Duan, J....&Huang, D..(2020).Clinical relevance of immune factors beyond CD8+T cells and mutation status of EGFR and ALK in patients with non-small cell lung cancer.ANNALS OF ONCOLOGY,31,
MLA:
Wang, K.,et al."Clinical relevance of immune factors beyond CD8+T cells and mutation status of EGFR and ALK in patients with non-small cell lung cancer".ANNALS OF ONCOLOGY 31.(2020):S809-S809